Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVianet Grp Regulatory News (VNET)

Share Price Information for Vianet Grp (VNET)

Share Price is delayed by 15 minutes
Get Live Data
69.50    0.50 (0.72%)
Bid:
67.00
Ask:
72.00
Spread: 5.00 (7.463%)
Market Cap: £19.76m
VNET Live PriceLast checked at - London Stock Exchange

Intraday Vianet Grp Share Chart

Further re shareholder enquiries

24 Sep 2009 07:00

RNS Number : 5732Z
Brulines Group PLC
24 September 2009
 



Brulines Group plc

(the "Company" or "Brulines")

Further re shareholder enquiries

Having received a number of enquiries from its own shareholders, Brulines confirms that it has made a preliminary approach to the board of Universe Group plc ("Universe"), relating to a potential offer for the issued and to be issued share capital of Universe. There can be no guarantee that any offer will be made and the Directors of Brulines expect that any offer would only be made following completion of due diligence, which has not yet taken place.

Currently, Brulines holds 9,560,618 Shares, representing 8.33 per cent. of Universe's issued share capital, with the highest price paid per share being 4.0p. The Directors of Brulines note that the closing share price of Universe on 23 September 2009 was 4.625p, a 63.3 per cent. premium to the average share price over the last six months.

Enquiries:-

 

James Dickson, Chief Executive

T: +44 (0)1642 358 800 

Stephen Keys/Camilla Hume/Adrian Hargrave, Cenkos Securities plc

T: +44 (0)20 7397 8900

Sarah Hollins/Mark Dixon, Abchurch Communications 

T: +44 (0)20 7398 7729

Rule 2.10 Requirement

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers, Brulines confirms that it currently has in issue 27,912,164 ordinary shares (excluding Treasury Shares) of 10p each. 

The International Securities Identification Number for the ordinary shares is GB00B13YVN56.

 

Dealing Disclosure Requirements:-

Under the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in one per cent. or more of any class of "relevant securities" of either Brulines or Universe, (together the "Companies"), all "dealings" in any "relevant securities" of these companies (including by means of an option in respect of, or a derivative referenced to, any such relevant securities) must be publicly disclosed by no later than 3.30pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which any offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of either of the Companies, they will be deemed to be a single person for the purpose of Rule 8.3. 

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of the Companies by the Companies or by the potential offeror, or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction. 

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the UK Panel on Takeovers and Mergers' (the "Panel") website at www.thetakeoverpanel.org.uk

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. 

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

The Company's Directors accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the Company's Directors (who have taken all reasonable care to ensure that such is the case), the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OFDLJMRTMMJTBJL
Date   Source Headline
26th Oct 20227:00 amRNSTrading Update and Notice of Results
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
22nd Sep 202210:49 amRNSDirector/PDMR Shareholding
16th Sep 20227:00 amRNSDirector/PDMR Shareholding
15th Sep 20229:50 amRNSDirector/PDMR Shareholding
4th Aug 20221:39 pmRNSDirector/PDMR Shareholdings
2nd Aug 20227:00 amRNSDirector/PDMR Shareholding
13th Jul 202211:26 amRNSResult of AGM
13th Jul 20227:01 amRNSDirectorate Changes
13th Jul 20227:00 amRNSAGM Statement
22nd Jun 20227:00 amRNSVianet Wins Two Awards at ‘The Vendies’ 2022
14th Jun 20227:00 amRNSFinal Results
3rd May 20221:28 pmRNSHolding(s) in Company
28th Apr 20227:00 amRNSTrading Update and Notice of Results
29th Mar 20221:47 pmRNSHolding(s) in Company
28th Mar 20225:55 pmRNSTransaction in Own Shares
28th Mar 20228:40 amRNSTransaction in Own Shares
18th Mar 20225:16 pmRNSTransaction in Own Shares
8th Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20222:54 pmRNSTransaction in Own Shares
25th Feb 202211:47 amRNSPurchase of Own Shares - Correction
24th Feb 20225:57 pmRNSPurchase of own shares
22nd Feb 20222:27 pmRNSShare Buyback
11th Jan 20227:00 amRNSContract Announcement
7th Dec 20217:00 amRNSInterim Results
27th Oct 20217:00 amRNSTrading Update and Notice of Results
24th Aug 202110:56 amRNSExercise of Options
13th Jul 202111:28 amRNSResult of AGM
13th Jul 20217:00 amRNSAGM Statement
15th Jun 20217:00 amRNSFinal Results
14th Apr 20217:00 amRNSTrading and COVID-19 Update and Notice of Results
8th Mar 20213:25 pmRNSDirector/PDMR Shareholding
3rd Feb 202110:01 amRNSDirector/PDMR Shareholding
15th Jan 20213:15 pmRNSDirector/PDMR Shareholding
14th Jan 20212:46 pmRNSDirector/PDMR Shareholding
14th Jan 20212:11 pmRNSDirector/PDMR Shareholding
8th Dec 202011:00 amRNSPrice Monitoring Extension
8th Dec 20207:00 amRNSInterim Results
1st Dec 20207:00 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSTrading Update and Notice of Interim Results
26th Aug 20207:00 amRNSTrading and COVID-19 Update
7th Aug 20202:40 pmRNSHolding(s) in Company
30th Jun 202011:30 amRNSResult of AGM
30th Jun 20207:00 amRNSAGM Statement
2nd Jun 20207:00 amRNSFinal Results
30th Mar 20207:05 amRNSDirector/PDMR Shareholding
26th Mar 20207:00 amRNSTrading and COVID-19 Update and Notice of Results
17th Mar 202012:26 pmRNSDirector/PDMR Shareholding
12th Mar 202011:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.